Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
0.642 %
$ 428 M
Market Cap
-3.15
P/E
EYPT - STOCK-BASED COMPENSATION
Stock-based Compensation EYPT - EyePoint Pharmaceuticals, Inc.
12.1 M
LAST VALUE
27.24%
2 YEAR CAGR
24.90%
5 YEAR CAGR
23.93%
10 YEAR CAGR